Wearable sensors for monitoring frontotemporal dementia
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study tests wearable sensors to remotely monitor people with frontotemporal dementia. It aims to help doctors track symptoms from home, which may reduce the need for clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years of age or older.
- You have a diagnosis of possible or probable frontotemporal dementia (FTLD).
- You can read and speak English.
- You have a caregiver or study partner who can help with study tasks.
- You have not had more than 5 falls in a month recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with neurodegenerative diseases, some family members, and healthy controls to help researchers better understand these conditions. It may help future diagnosis and research, and participation may include noninvasive checks and other procedures depending on your situation.
This study uses a wearable sensor and a phone app to track how frontotemporal degeneration affects movement and speaking. If you have FTD, this could help doctors detect changes earlier and improve care.
This study follows people with frontotemporal dementia (FTLD) and related conditions, and collects health and (for some people) body fluid information, to understand how these illnesses change over time. It may help researchers track disease signs and find better ways to measure progression.
This study tests a non-invasive brain stimulation technique called tACS (transcranial alternating current stimulation) in people with frontotemporal dementia. The goal is to see if it can improve symptoms like behavior and language problems.
This study is testing whether digital health tools (like wearable sensors) can better track symptoms of certain brain conditions (PSP, DLB, and MCI with Lewy bodies). It aims to improve monitoring and care for people with these conditions.
This study tests how well remote monitoring tools, like wearable devices, can track symptoms in people with movement disorders like PSP, Parkinson's disease, or MSA. The goal is to see if these tools can help doctors better understand how the disease progresses from home.
Hear when a new Frontotemporal Lobar Degeneration (FTLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.